Latest News

Strong commitment to Research and Innovation: 45 scientific contributions of FME at the WCN 2013

wcn logo1


With a clear research focus on fluid management to improve patient outcomes, Fresenius Medical Care presented their latest study results in Hong Kong during this year's WCN.

PERNEFRI Annual Meeting & Workshop 2013

pernefri logo3


Are you attending this year’s PERNEFRI Annual Meeting? Come and visit us at our booth (#3-4) and find out what’s new at Fresenius Medical Care.

50th ERA-EDTA Congress - Press Release Fresenius Medical Care

online hdr


High Volume HDF improves patient survival

The Catalonian Online Haemodiafiltration Survival Study (ESHOL) published in February 2013 confirms Fresenius Medical Care’s conviction that every patient should be given the chance to benefit from haemodiafiltration (HDF) therapy with high volumes of substitution fluid (HighVolumeHDF). The primary outcome of the study was that HighVolumeHDF therapy significantly improves patient survival compared with conventional dialysis treatment. At this year’s ERA-EDTA Congress, HighVolumeHDF was the main focus of Fresenius Medical Care’s activities.

New meta-analysis demonstrates that high-flux haemodialysis may reduce cardiovascular mortality by 17% compared with low-flux haemodialysis

fx8 fx10





Cardiovascular and non-cardiovascular mortality rates for people commencing haemodialysis are nearly 30 to 50 times higher than for the general population. It has been suggested that removal of larger solutes across high-flux haemodialysis membranes may better reflect normal kidney function and improve cardiovascular outcomes versus low-flux haemodialysis. Here we report results from a meta-analysis investigating this hypothesis.

EDTA International Fellowship Program extends its sponsorships to Asia

lab tech

The ERA-EDTA (European Renal Association-European Dialysis and Transplant Association) aims to encourage and report advances in the field of clinical nephrology, dialysis, renal transplantation and related subjects1. Here we provide information on their International Clinical Fellowship Program now open to young Asian investigators and clinicians including those in Indonesia.